KalVista Pharmaceuticals (KALV) Climbs 140%
- Wall Street ends lower as investors await earnings, inflation data
- Microsoft (MSFT) announces $19.7 billion acquisition of Nuance (NUAN)
- Dollar drops as traders prepare for inflation data
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
KalVista Pharmaceuticals (NASDAQ: KALV) Climbs 140%
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nuance Communications (NUAN) Halted, News Pending
- Kodak (KODK) Announces DZZ Druckzentrum Zurich commits fully to the KODAK LIBRA VP2 Digital Plate
- iRhythm Technologies (IRTC) Sinks as Novitas Posted Revised Extended ECG Rates